Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EL-102 is a HIF1α inhibitor with anticancer activity that inhibits microtubule protein polymerization and can be used to study prostate cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 89.00 | |
5 mg | In stock | $ 228.00 | |
10 mg | In stock | $ 368.00 | |
25 mg | In stock | $ 573.00 | |
50 mg | In stock | $ 778.00 | |
100 mg | In stock | $ 1,160.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 193.00 |
Description | EL-102 is a HIF1α inhibitor with anticancer activity that inhibits microtubule protein polymerization and can be used to study prostate cancer. |
Targets&IC50 | PC3:37.0 nM, CWR22:24 nM, DLKP:14.4 nM, 22Rv1:21.7 nM, DU145 cells:40.3 nM, DLKPA:16.3 nM |
In vitro | In CWR22, 22Rv1, DU145, PC-3, DLKP, and doxorubicin-selected variant DLKPA cell lines, EL-102 (0-120 nM; 72 hours) inhibited cell proliferation with IC50 values of 24, 21.7, 40.3, 37.0, 14.4, and 16.3 nM, respectively[1]. |
In vivo | In nude mice bearing CWR22 xenografts, EL-102 (oral gavage; 12 and 15 mg/kg; administered every 5 days with 2 days off) showed no effect on tumor growth but enhanced the effect of docetaxel on the tumor[1]. |
Synonyms | EL102 |
Molecular Weight | 384.47 |
Formula | C19H16N2O3S2 |
CAS No. | 1233948-61-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL (52.02 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EL-102 1233948-61-2 Angiogenesis Chromatin/Epigenetic Cytoskeletal Signaling Microtubule Associated HIF EL 102 EL102 inhibitor inhibit